NCT05635669 Optimized Acupuncture Treatment for Female Stress Urinary Incontinence
| NCT ID | NCT05635669 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yin Ping |
| Condition | Stress Urinary Incontinence |
| Study Type | INTERVENTIONAL |
| Enrollment | 360 participants |
| Start Date | 2023-01-04 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 360 participants in total. It began in 2023-01-04 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This multicenter randomized controlled trial is designed to explore a relatively suitable application of acupoint combinations and to provide certain clinical evidence for the optimization of acupuncture treatment of female SUI.
Eligibility Criteria
Inclusion Criteria: * Patients with mild to moderate SUI mentioned in the diagnostic criteria above; * Aged 40～75 years; * Sign the informed consent. Exclusion Criteria: * Other types of urinary incontinence (urgent, overflow or mixed). * History of urinary incontinence surgery or pelvic floor surgery; * Pelvic organ prolapse ≥ stage II; * Symptomatic urinary tract infection; * Residual urine volume \> 30 mL; * Maximum urinary flow rate \< 20ml/s. * Limitation of movement (walk and/or run and/or climb stairs); * Patients who have been using drugs that may affect bladder function or receiving SUI specialized treatment; * Severe cardiovascular, cerebral, liver, kidney and hematopoietic system disease, mental disorders, diabetes, multiple system atrophy, cauda equina neuropathy and spinal cord disease; * Pregnancy or lactation period. * With cardiac pacemaker, acupuncture phobia or metal allergies;
Contact & Investigator
YUELAI CHEN
PRINCIPAL INVESTIGATOR
Shanghai University of Traditional Chinese Medicine
Frequently Asked Questions
Who can join the NCT05635669 clinical trial?
This trial is open to female participants only, aged 40 Years or older, up to 75 Years, studying Stress Urinary Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05635669 currently recruiting?
Yes, NCT05635669 is actively recruiting participants. Contact the research team at bingxue616@163.com for enrollment information.
Where is the NCT05635669 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT05635669 clinical trial?
NCT05635669 is sponsored by Yin Ping. The principal investigator is YUELAI CHEN at Shanghai University of Traditional Chinese Medicine. The trial plans to enroll 360 participants.